Will Aerie Pharmaceuticals Hold its Support Level?
StockNews
Published Jul 23, 2021 09:49AM ET
Updated Jul 23, 2021 10:31AM ET
Will Aerie Pharmaceuticals Hold its Support Level?
Aerie Pharmaceuticals (AERI) is approaching a support level. If this support level is broken, a breakdown is expected.Aerie Pharmaceuticals, Inc. (AERI) engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye.
Take a look at the 1-year chart of AERI below with added notations:
After its October to January rally, AERI has settled on top of a key level of support at $15 (green). The stock appears to be falling back down to that support again, and another bounce could start from there. However, a break of $15 could mean much lower prices for the stock.
Continue reading on StockNews
Get The News You Want
Written By: StockNews
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.